Who is sponsoring NCT01277081?

NCT01277081 is sponsored by GlaxoSmithKline.

What condition does NCT01277081 study?

NCT01277081 studies Common Cold.

What drugs are being tested in NCT01277081?

Interventions: Paracetamol hot drink, Paracetamol tablets.

What is the status of NCT01277081?

NCT01277081 is currently COMPLETED.

Last reviewed 2015-02-02 · How we verify

To Assess the Subjective Effect of Two Paracetamol Preparations on the Feeling of Breathing in Subjects With the Common Cold.

NCT01277081 Phase 2 COMPLETED Results posted

The aim of this study is to subjectively assess symptoms in subjects suffering from the common cold following a single dose of paracetamol hot drink compared to paracetamol tablet

Details

Lead sponsor	GlaxoSmithKline
Phase	Phase 2
Status	COMPLETED
Enrolment	200
Start date	2010-10
Completion	2010-12

Conditions

Common Cold

Interventions

Paracetamol hot drink
Paracetamol tablets

Primary outcomes

Breathing Scores Post 15 Minutes — Baseline to 15 minutes
A mean breathing score was calculated at baseline, 30 seconds, 2, 5 and 15 minutes, derived from participant responses to questions relating to breathing i.e. "my breathing feels easy", "I feel airways are open", "I feel a cooling sensation in my throat", "I can feel the air flowing to my lungs easily", "My nose feels less blocked" and "I feel my breathing is comfortable". The breathing scores were rated by the participants on a 5 point (0-4) rating scale with '0' being labeled as 'strongly disagree' and '4' being labeled as 'strongly agree'. For each participant, a mean score was derived by summing the responses and dividing by the number of questions answered.

Countries

United Kingdom